Physician profile
Mina Armanious
NPI 1063070068
$1,160.88
in general payments reported to CMS, 2019-2025
7 companies · $626 in 2025
The $626 reported for 2025 was more than what 92% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.33 · 2020: $16.65 · 2023: $299 · 2024: $199 · 2025: $626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $708 · Education: $400 · Gift: $17.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $707.50 |
| Education | $400.00 |
| Gift | $17.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $576.11 | 2023-2025 | Invisalign, Itero Element 5d Plus |
| Zimvie INC. | $311.67 | 2023-2025 | |
| Envista Holdings Corporation | $171.64 | 2024-2025 | Endodontics, Optibond Solo Plus |
| Dentsply Sirona INC | $35.98 | 2019-2020 | |
| 3m Company | $28.33 | 2023 | Impregum Super Quick, 3m Espe Filtek Supreme Ultra Universal Restorative, Attest |
| Sonendo INC | $21.30 | 2023 | Gentlewave G4 Console, Gentlewave Console |
| Gc America INC. | $15.85 | 2025 | Cerasmart, Gc Initial, G-Cem One |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mina Armanious listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.